Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Blahová
J
J
Králiková
K
K
Krcméry
V
V
Kubonová
K
K
D000077723:Cefepime; D002442:Ceftazidime / Q000378:metabolism* / Q000627:therapeutic use; D002511:Cephalosporins / Q000378:metabolism* / Q000627:therapeutic use; D003428:Cross Infection / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D005417:Flavobacterium / Q000378:metabolism*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D006868:Hydrolysis; D015378:Imipenem / Q000378:metabolism* / Q000627:therapeutic use; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D013845:Thienamycins / Q000378:metabolism* / Q000627:therapeutic use
D002511:Cephalosporins; D013845:Thienamycins; D015378:Imipenem; D000077723:Cefepime; D002442:Ceftazidime; D000077731:Meropenem